$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Substituted benzimidazole dosage forms and methods of using same 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/4439
출원번호 US-0054350 (2002-01-19)
발명자 / 주소
  • Phillips, Jeffrey O.
출원인 / 주소
  • The Curators of the University of Missouri
대리인 / 주소
    Mahoney, Joseph A.Mayer, Brown, Rowe & Maw LLP
인용정보 피인용 횟수 : 71  인용 특허 : 93

초록

Disclosed herein are methods, kits, combinations, and compositions for treating gastric acid disorders employing pharmaceutical compositions comprising a proton pump inhibiting agent (PPI) and a buffering agent in a pharmaceutically acceptable carrier.

대표청구항

Disclosed herein are methods, kits, combinations, and compositions for treating gastric acid disorders employing pharmaceutical compositions comprising a proton pump inhibiting agent (PPI) and a buffering agent in a pharmaceutically acceptable carrier. -5418254, 19950500, Huang et al.; US-5420287, 1

이 특허에 인용된 특허 (93)

  1. Senn-Bilfinger Jrg (Constance DEX), 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects.
  2. Caruso Michele (Milan ITX) Suarato Antonino (Milan ITX) Angelucci Francesco (Milan ITX) Arcamone Federico (Milan ITX), 4-demethoxy-4-amino-anthracyclines.
  3. Spickett Robert G. W. (Barcelona ESX) Vidal Jose L. F. (Barcelona ESX) Escoi Juan C. (Barcelona ESX), Antacid compositions with prolonged gastric residence time.
  4. Olsson Bert-.ANG.ke,SEX, Aseptic transfer.
  5. Brndstrm Arne E. (Gothenburg SEX), Base addition salts of omeprazole.
  6. Berntsson Peder Bernhard (Molndal SW) Carlsson Stig Ake Ingemar (Molnlycke SW) Garberg Lars Erik (Molnlycke SW) Junggren Ulf Krister (Pixbo SW) Sjostrand Sven Erik (Kungsbacka SW) VON Wittken Sundell, Benzimidazole derivatives useful as gastric acid secretion inhibitors.
  7. Brandstrom, Arne E.; Lamm, Bo R., Certain pyridyl-N-oxide intermediates for the preparation of omeprazole.
  8. Alminger Tomas B. (Lindome SEX) Bergman Rolf A. (Molndal SEX) Bundgaard H. (Horsholm DKX) Lindberg Per L. (Askim SEX) Sunden Gunnel E. (Gothenburg SEX), Certain pyridyl[(methylthio- or methyl sulfinyl)-2 benzimidazol-2-yl]N-methyl phosphonates useful for treating gastric-a.
  9. Lindberg Per Lennart,SEX ; Von Unge Sverker,SEX, Compositions.
  10. Lindberg Per Lennart,SEX ; von Unge Sverker,SEX, Compounds.
  11. Fain Gordon L. (Los Angeles CA) Lee David A. (Los Angeles CA) Lindberg Per L. (Askim CA SEX) Sachs George (Cure Wadsworth CA), Compounds including omeprazole in the treatment of glaucoma.
  12. Lovqvist Karin,SEX ; Sunden Gunnel,SEX ; Noreland David,SEX ; Ymen Ingvar,SEX, Crystalline form of omeprazole.
  13. Bohlin Martin,SEX ; Horvath Karol,SEX, Crystalline form of the S-enantiomer of omeprazole.
  14. Briving Carin B. (Billdal SEX) Carlsson Stig A. I. (Mlnlycke SEX) Lindberg Per L. (Askim SEX) Mattsson Annie H. (Askim SEX) Nordberg Mats P. (Gothenburg SEX) Wallmark Bjrn M. G. (Mlnlycke SEX), Derivatives of benzimidazoles active as anti-ulcer agents.
  15. Lindberg Per L. (Askim SEX) Sundn Gunnel E. (Gteborg SEX), Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use.
  16. Berglund Bengt G. (Gteborg SEX), Dissolution system.
  17. Veronesi Paolo Alberto,ITX, Drug delivery system.
  18. Tomohisa Matsushita,JPX ; Mitsuo Hashimoto,JPX, Enteric granule-containing tablets.
  19. Junggren Ulf K. (Mlnlycke SEX) Sjstrand Sven E. (Kungsbacka SEX), Gastric acid secretion inhibiting substituted 2-(2-benzimidazolyl)-pyridines, pharmaceutical preparations containing sam.
  20. Junggren Ulf K. (Mlnlycke SEX) Sjstrand Sven E. (Kungsbacka SEX), Gastric acid secretion inhibiting substituted 2-(2-benzimidazolyl)-pyridines, their preparation, pharmaceutical preparat.
  21. Shell John W. ; Louie-Helm Jenny, Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter.
  22. McCullough Ricky W. (165 Crary St. Providence RI 02903), Gastrointestinal anti-irritant composition comprising sucralfate and methods of use.
  23. Upson James G. (Springdale OH) Russell Carmelita M. (Cincinnati OH), Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress.
  24. Nelson Sandra Lynn, Inhibiting undesirable taste in oral compositions.
  25. Nakanishi Shigeo (Neyagawa JPX) Tominaga Tetsuo (Itami JPX) Yamanaka Iwao (Osaka JPX) Higo Takashi (Ikeda JPX) Shibata Toshiyuki (Nakatsu JPX), Injection and injection kit containing omeprazole and its analogs.
  26. Eoga Anthony B. ; Valia Kirti H., Method for making fast-melt tablets.
  27. Graham Daniel,GBX ; Holt Robert,GBX ; Lindberg Per,SEX ; Taylor Stephen,GBX, Method for preparing a pharmaceutically active enantiomeric or enantiomerically enriched sulfoxide compound by enantios.
  28. Min Dong S. (Seoul KRX) Um Kee A. (Suwon KRX) Kim Yong S. (Suwon KRX) Park Pyong W. (Seoul KRX), Method for preparing enteric-coated oral drugs containing acid-unstable compounds.
  29. Gustavsson Anders,SEX ; Kallstrom .ANG.ke,SEX, Method for the synthesis of a benzimidazole compound.
  30. Lindberg Per,SEX ; Weidolf Lars,SEX, Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazol.
  31. Hasselkus Wolfgang,DEX, Method for treatment of psoriasis, by omeprazole or related compounds.
  32. Lundberg Per Johan,SEX ; Lovgren Kurt,SEX, Method of making a pharmaceutical dosage form comprising a proton pump inhibitor.
  33. Brndstrm Arne E. (Gothenburg SEX), Method of synthesis of 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl-1H-benzimidazole (omeprazole).
  34. Makino Tadashi (Osaka JPX) Tabata Tetsuro (Osaka JPX) Hirai Shin-Ichiro (Kyoto JPX), Method to stabilize a pharmaceutical composition and its production.
  35. Catrenich Carl E. (Fairfield OH) Nelson Dennis G. A. (West Chester OH), Methods and compositions of diphenyl ether phosphate esters for the treatment of gastrointestinal disorders.
  36. Ruwart Mary J. (Kalamazoo MI), Methods for treating gastrointestinal inflammation.
  37. Lundberg Per Johan,SEX ; Thune Mikael,SEX, Multiple unit effervescent dosage form.
  38. Lundberg Per Johan,SEX, Multiple unit effervescent dosage forms comprising proton pump inhibitor.
  39. Bergstrand Pontus John Arvid,SEX ; Lovgren Kurt Ingmar,SEX, Multiple unit pharmaceutical preparation.
  40. Bergstrand Pontus John Arvid,SEX ; Lovgren Kurt Ingmar,SEX, Multiple unit tableted dosage form of omeprazole.
  41. Krasso Anna (Basel CHX) Krebs Ernst-Peter (Bottmingen CHX), Naphth[2,3-d]imidazoles.
  42. Brndstrm Arne E. (Gteborg SEX) Carlsson Stig A. I. (Mlnlycke SEX) Kllsson Britt I. M. (Mlndal SEX) Lindberg Per L. (Askim SEX), Novel pharmacologically active compound pyridyl methylsulfinyl benzimidazole.
  43. Kim Kwang Sik (11-43 ; Yeonmu-dong Jangan-gu ; Suwon ; Kyunggi-do KRX), Omeprazole compositions designed for administration in rectum.
  44. Kallstrom Lars .ANG.ke,SEX ; Nygren Monica Annelie,SEX, Omeprazole magnesium salt form.
  45. Anousis Nick ; McManus James W. ; Banks Benjamin Newton ; Zhou Lingwen, Omeprazole process and compositions thereof.
  46. Anousis Nick ; McManus James W. ; Banks Benjamin Newton ; Zhou Lingwen ; Liu Hui, Omeprazole process and compositions thereof.
  47. Phillips Jeffrey Owen, Omeprazole solution and method for using same.
  48. Nilsen Stephen James ; Walden Gary Lyle, Oral compositions having enhanced mouth-feel.
  49. Sachs George ; Dietrich Rango,DEX, Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole.
  50. Depui Helene,SEX ; Rosinski Adam,SEX, Oral pharmaceutical dosage form.
  51. Depui Helene,SEX ; Hallgren Agneta,SEX, Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent.
  52. Depui Helene,SEX ; Hallgren Agneta,SEX, Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate.
  53. Palomo Coll Alberto (Barcelona ESX), Oral pharmaceutical preparation containing omeprazol.
  54. Goldman William J. (Ambler PA) Gates Thomas N. (Doylestown PA), Pharmaceutical compositions and methods for treating the symptoms of overindulgence.
  55. Bengtsson Inga Siv (Goteborg SEX) Lovgren Kurt Ingmar (Molnlycke SEX), Pharmaceutical formulation of omeprazole.
  56. Erickson Magnus,SEX ; Josefsson Lars,SEX, Pharmaceutical formulation of omeprazole.
  57. Bolt Ian James,GBX ; Merrifield David Roy,GBX ; Carter Paul Laurence,GBX, Pharmaceutical formulation with effervescent couple.
  58. Lovgren Kurt I. (Mlnlycke SEX) Pilbrant Ake G. (Kungsbacka SEX) Yasumura Mitsuru (Hyogo JPX) Morigaki Satoshi (Hyogo JPX) Oda Minoru (Ohita JPX) Ohishi Naohiro (Fukuoka JPX), Pharmaceutical formulations of acid labile substances for oral use.
  59. Lovgren Kurt I. (Mlnlycke SEX) Pilbrant Ake G. (Kungsbacka SEX) Yasumura Mitsuru (Hyogo JPX) Morigaki Satoshi (Hyogo JPX) Oda Minoru (Ohita JPX) Ohishi Naohiro (Fukuoka JPX), Pharmaceutical preparation for oral use.
  60. Augello Michael ; Dell Sheila M. ; Agyilirah George A. ; Reier George E., Pharmaceutical suspension tablet compositions.
  61. Hamley Peter,GBX ; Pimm Austen,GBX ; Tinker Alan,GBX ; Beaton Haydn,GBX ; McInally Thomas,GBX, Pharmaceutically active compounds.
  62. Slemon Clarke (North York CAX) Macel Bob (Thornhill CAX), Preparation of omeprazole and lansoprazole.
  63. Slemon Clarke (North York CAX) Macel Bob (Thornhill CAX), Preparation of omeprazole and lansoprazole, and intermediates useful therein.
  64. Fuisz Richard C. ; Cherukuri Subraman R. ; Kota Suresh B. ; Stewart James L., Process for forming chewable quickly dispersing multi-vitamin preparation and product therefrom.
  65. Von Unge Sverker (Fjars SEX), Process for preparing pure salts of pyridinylmethyl-sulfinyl-1H-benzimidazole.
  66. Makino Tadashi,JPX ; Tabata Tetsuro,JPX ; Hirai Shin-Ichiro,JPX, Process for producing stabilized pharmaceutical composition.
  67. Makino Tadashi,JPX ; Tabata Tetsuro,JPX ; Hirai Shin-Ichiro,JPX, Process for producing stabilized pharmaceutical composition.
  68. Larsson Magnus Erik,SEX ; Stenhede Urban Jan,SEX ; Sorensen Henrik,SEX ; von Unge Sverker Per Oskar,SEX ; Cotton Hanna Kristina,SEX, Process for synthesis of substituted sulphoxides.
  69. Von Unge Sverker,SEX, Process for the optical purification of enantiomerically enriched benzimidazole derivatives.
  70. Hogberg Jan-.ANG.ke,SEX ; Ioannidis Panagiotis,SEX ; Mattson Anders,SEX, Process for the preparation of a magnesium salt of a substituted sulfinyl heterocycle.
  71. Hoerrner Robert S. (Scotch Plains NJ) Friedman Joel J. (East Brunswick NJ) Amato Joseph S. (Brooklyn NY) Liu Thomas M. (Westfield NJ) Shinkai Ichiro (Westfield NJ) Weinstock Leonard M. (Hilton Head S, Process for the preparation of antiulcer agents.
  72. Brndstrm Arne E. (Gteborg SEX) Lamm Bo R. (Gteborg SEX), Processes for the preparation of omeprazole and intermediates therefore.
  73. Kawakita Takeshi (Fukuoka JPX) Sano Mitsuharu (Fukuoka JPX) Yutoku Yuko (Fukuoka JPX) Ikeda Yoshifumi (Fukuoka JPX) Haga Keiichiro (Fukuoka JPX), Pyridine compound and pharmaceutical compostions.
  74. Gowan ; Jr. Walter G., Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof.
  75. Wright Paul G. (Pleasant Dale NE) Nabity Frederick A. (Lincoln NE), Sample collector.
  76. Iwahi Tomoyuki (Suita JPX) Satoh Hiroshi (Suita JPX), Selective antibacterial agent against campytobacter.
  77. Patel Mahesh V. ; Chen Feng-Jing, Solid carriers for improved delivery of active ingredients in pharmaceutical compositions.
  78. Makino Tadashi,JPX ; Tabata Tetsuro,JPX ; Hirai Shin-Ichiro,JPX, Stabilized pharmaceutical composition.
  79. Makino Tadashi (Osaka JPX) Tabata Tetsuro (Osaka JPX) Hirai Shin-ichiro (Kyoto JPX), Stabilized pharmaceutical composition and its production.
  80. Makino Tadashi (Osaka JPX) Tabata Tetsuro (Osaka JPX) Hirai Shin-ichiro (Kyoto JPX), Stabilized pharmaceutical composition and its production.
  81. Debregeas Patrice (Versailles FRX) Leduc Grard (Malesherbes FRX), Stable compositions of gastroprotected omerprazole microgranules and process for the production thereof.
  82. Junggren Ulf K. (Mlnlycke SEX) Sjstrand Sven E. (Kungsbacka SEX), Substituted 2-(-benzimidazolyl)pyridines.
  83. Brndstrm Arne E. (Gothenburg SEX) Lindberg Per L. (Askim SEX) Wallmark Bjrn (Mlnlycke SEX), Sulphenamides.
  84. Eek Arne T. (Trosa SEX) Sjostrand Sven E. (Sodertalje SEX), Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic.
  85. Eek Arne T. (Trosa SEX) Sjostrand Sven Erik (Sodertalje SEX), Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic.
  86. Eek Arne T. (Trosa SEX) Sjostrand Sven Erik (Sodertalje SEX), Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic.
  87. Kawakita Takeshi (Nakatsu JPX) Chihara Yasuaki (Yoshitomi JPX) Fukuda Takemi (Shinyoshitomi JPX) Setoguchi Michihide (Nakatsu JPX) Tahara Tetsuya (Nakatsu JPX), Tetrahydrofuran compounds and analogs thereof.
  88. Brndstrm Arne E. (Gteborg SEX) Lindberg Per L. (Askim SEX) Starke Carl I. (Gteborg SEX) Sundn Gunnel E. (Gteborg SEX), Therapeutically active chloro substituted benzimidazole.
  89. Brndstrm Arne E. (Gteborg SEX) Lindberg Per L. (Askim SEX) Sunden Gunnel E. (Gteborg SEX), Therapeutically active compound and a process for its preparation.
  90. Brndstrm Arne E. (Gothenburg SEX) Lindberg Per L. (Askim SEX) Sunden Gunnel E. (Gothenburg SEX), Therapeutically active fluoro-substituted compound.
  91. Ruwart Mary J. (Kalamazoo MI) Im Wha B. (Portage MI), Transdermal antisecretory agents for gastrointestinal disease.
  92. Tomoi Masaaki (Higashi-Osaka JPX) Ikeda Yoshifumi (Nakatsu JPX) Yokota Yoshiko (Ibaraki JPX), Use of omeprazole as an antimicrobial agent.
  93. Olovson Stig-Goran Arthur,SEX ; Pilbrant .ANG.ke Gunnar,SEX, Veterinary composition.

이 특허를 인용한 특허 (71)

  1. Kostadinov, Aleksey; David, Ayelet; Glozman, Sabina, Composition and methods for inhibiting gastric acid secretion.
  2. Phillips, Jeffrey O., Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same.
  3. Phillips, Jeffrey O., Composition comprising omeprazole, lansoprazole and at least one buffering agent.
  4. Plachetka, John R., Compositions and methods for delivery of omeprazole plus acetylsalicylic acid.
  5. Plachetka, John R., Compositions and methods for delivery of omeprazole plus acetylsalicylic acid.
  6. Kostadinov, Aleksey; Atarot, Tal; Naveh, Michael, Compositions and methods for inhibiting gastric acid secretion.
  7. Kostadinov, Aleksey; Ayelet, David; Glozman, Sabina; Atarot, Tal, Compositions and methods for inhibiting gastric acid secretion.
  8. Kostadinov, Aleksey; Ayelet, David; Glozman, Sabina; Atarot, Tal, Compositions and methods for inhibiting gastric acid secretion.
  9. Kostadinov, Aleksey; David, Ayelet; Glozman, Sabina, Compositions and methods for inhibiting gastric acid secretion.
  10. Marash, Michael; Kostadinov, Aleksey; Atarot, Tal, Compositions and methods for inhibiting gastric acid secretion using derivatives of small dicarboxylic acids in combination with PPI.
  11. Fallon, Joan M.; Heil, Matthew; Fallon, James J., Compositions and methods for the treatment or the prevention of E. coli infections and for the eradication or reduction of E. coli surfaces.
  12. Odidi, Isa; Odidi, Amina, Controlled extended drug release technology.
  13. Odidi, Isa; Odidi, Amina, Controlled release delivery device comprising an organosol coat.
  14. Sutherland, David Clayton; Zorn, James Kyle; Carlo, Dennis J., Drug compositions comprising an anti-parasitic and proton pump inhibitor.
  15. Fallon, Joan M.; Heil, Matthew, Enzyme delivery systems and methods of preparation and use.
  16. Fallon, Joan M.; Heil, Matthew, Enzyme delivery systems and methods of preparation and use.
  17. Fallon, Joan M.; Heil, Matthew, Enzyme delivery systems and methods of preparation and use.
  18. DiPerna, Paul M, Flow regulating stopcocks and related methods.
  19. Pettersson, Anders, Gastric acid secretion inhibiting composition.
  20. Pettersson, Anders; Nyström, Christer; Håkansson, Yvonne, Gastric acid secretion inhibiting composition.
  21. DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  22. DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  23. Michaud, Michael; Kruse, Geoffrey A., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  24. Michaud, Michael; Kruse, Geoffrey A., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  25. Verhoef, Erik T.; DiPerna, Paul M.; Rosinko, Mike; Williamson, Mark; Kruse, Geoffrey A.; Ulrich, Thomas R.; Lamb, Phil; Saint, Sean; Michaud, Michael; Trevaskis, William, Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
  26. Gant, Thomas G.; Sarshar, Sepehr, Inhibitors of the gastric H, K-ATPase with enhanced therapeutic properties.
  27. Ault, Brian; Orlemans, Everardus; Plachetka, John R.; Sostek, Mark, Method for delivering a pharmaceutical composition to patient in need thereof.
  28. Ault, Brian; Orlemans, Everardus; Plachetka, John R.; Sostek, Mark, Method for delivering a pharmaceutical composition to patient in need thereof.
  29. Ault, Brian; Sostek, Mark; Orlemans, Everardus; Plachetka, John R., Method for delivering a pharmaceutical composition to patient in need thereof.
  30. Ault, Brian; Hwang, Clara; Orlemans, Everardus; Plachetka, John R; Sostek, Mark, Method for treating a patient at risk for developing an NSAID-associated ulcer.
  31. Fallon, Joan M., Method for treating pervasive development disorders.
  32. Fallon, Joan M., Method for treating pervasive development disorders.
  33. Fallon, Joan M., Method of treating proteinuria in pregnancy.
  34. Rosinko, Michael J.; DiPerna, Paul M., Methods and devices for determination of flow reservoir volume.
  35. Rosinko, Michael J; DiPerna, Paul M., Methods and devices for determination of flow reservoir volume.
  36. Fallon, Joan M., Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions.
  37. Glozman,Sabina, Methods for treatment of-associated disorders.
  38. Phillips, Jeffrey O., Omeprazole solution and method for using same.
  39. Odidi, Isa; Odidi, Amina, Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors.
  40. Roberts, Michael Stephen; Jiang, Ruoying; Bezanehtak, Keivan; Davey, Greg Andrew; Davidson, George Alexander; Elliott, Geraldine Ann; Chandler, Stephen Douglas; Sarkar, Mantu, Oral paracetamol formulations.
  41. Roberts, Michael Stephen; Davidson, George Alexander; Jiang, Ruoying; Elliott, Geraldine Ann; Bezanehtak, Keivan; Chandler, Stephen Douglas; Davey, Greg; Sarkar, Mantu, Oral therapeutic compound delivery system.
  42. Venkata Ramana Rao, Sripriya; Shah, Syed M.; Tatapudy, Hanumantharao; Saunders, Richard William; Fawzi, Mahdi; Nagi, Arwinder; Singh, Shailesh; Hasan, Sumon A, Pantoprazole multiparticulate formulations.
  43. Venkata Ramana Rao, Sripriya; Shah, Syed M.; Tatapudy, Hanumantharao; Saunders, Richard William; Fawzi, Mahdi; Nagi, Arwinder; Singh, Shailesh; Hasan, Sumon A, Pantoprazole multiparticulate formulations.
  44. Venkata Ramana Rao, Sripriya; Shah, Syed M.; Tatapudy, Hanumantharao; Saunders, Richard William; Fawzi, Mahdi; Nagi, Arwinder; Singh, Shailesh; Hasan, Sumon A., Pantoprazole multiparticulate formulations.
  45. Venkata Ramana Rao, Sripriya; Shah, Syed M.; Tatapudy, Hanumantharao; Saunders, Richard William; Fawzi, Mahdi; Nagi, Arwinder; Singh, Shailesh; Hasan, Sumon A., Pantoprazole multiparticulate formulations.
  46. Odidi, Isa; Odidi, Amina, Pharmaceutical composition having reduced abuse potential.
  47. Plachetka, John R., Pharmaceutical compositions for the coordinated delivery of NSAIDS.
  48. Plachetka, John R., Pharmaceutical compositions for the coordinated delivery of NSAIDs.
  49. Plachetka, John R., Pharmaceutical compositions for the coordinated delivery of NSAIDs.
  50. Plachetka, John R., Pharmaceutical compositions for the coordinated delivery of NSAIDs.
  51. Plachetka, John R., Pharmaceutical compositions for the coordinated delivery of NSAIDs.
  52. Plachetka, John R., Pharmaceutical compositions for the coordinated delivery of NSAIDs.
  53. Plachetka, John R., Pharmaceutical compositions for the coordinated delivery of NSAIDs.
  54. Plachetka, John R., Pharmaceutical compositions for the coordinated delivery of NSAIDs.
  55. Plachetka, John R., Pharmaceutical compositions for the coordinated delivery of NSAIDs.
  56. Plachetka, John R., Pharmaceutical compositions for the coordinated delivery of NSAIDs.
  57. Hall, Warren; Olmstead, Kay; Weston, Laura, Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them.
  58. Olmstead, Kay; Hall, Warren; Proehl, Gerald T., Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them.
  59. Olmstead, Kay; Hall, Warren; Proehl, Gerald T., Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them.
  60. Fallon, Joan M., Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same.
  61. Odidi, Isa; Odidi, Amina, Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient.
  62. Odidi, Isa; Odidi, Amina, Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient.
  63. Odidi, Isa; Odidi, Amina, Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems.
  64. DiPerna, Paul M., Slideable flow metering devices and related methods.
  65. Brown, David, Solute concentration measurement device and related methods.
  66. Brown, David, Solute concentration measurement device and related methods.
  67. Lahav, Raffael; Azoulay, Valerie, Stable benzimidazole formulation.
  68. Phillips,Jeffrey Owen, Substituted benzimidazole dosage forms and method of using same.
  69. Rosinko, Michael J.; Kruse, Geoffrey A.; Harris, Paul, System and method for detecting occlusions in an infusion pump.
  70. Metzmaker, Thomas; Saint, Sean; Michaud, Michael; Rosinko, Michael J.; Swanson, Vance, Systems including vial adapter for fluid transfer.
  71. DiPerna, Paul M., Two chamber pumps and related methods.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로